Home » Topics » Conferences

Conferences
RSS

SynPhar selects class C beta-lactamase inhibitor as development candidate

Oct. 2, 1997

T-3811: a new des-F(6)-quinolone from Toyama presented at ICAAC

Oct. 2, 1997

Wakunaga develops new oral fluoroquinolones

Oct. 2, 1997

BioChem Therapeutic discovers new anti-HCMV agents

Oct. 2, 1997

New polyene antifungal antibiotic developed at Ajinomoto

Oct. 2, 1997

Quinacrine sterilization reviewed

Oct. 2, 1997

Safety profile of VRCTC-310 established in rabbits

Oct. 2, 1997

ABT-606: a new orally active diester prodrug of H2G

Oct. 1, 1997

New agents for NIDDM presented by Pharmacia & Upjohn

Oct. 1, 1997

A-5021: a potent and selective antiherpesvirus agent from Ajinomoto

Oct. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...